Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5,595.00
-95.00 (-1.67%)
Jul 31, 2025, 5:24 PM IDT

TLV:TEVA Revenue

Teva Pharmaceutical Industries had revenue of $4.18B USD in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to $16.63B, up 2.07% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.63B
Revenue Growth
+2.07%
P/S Ratio
1.07
Revenue / Employee
$465.95K
Employees
35,686
Market Cap
60.21B ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Danel (Adir Yeoshua)2.81B
Kamada622.70M
Bait Bakfar104.50M
SofWave Medical235.09M
BrainsWay161.81M
Novolog (Pharm-Up 1966)2.07B
Ilex Medical922.08M
Epitomee Medical37.17M
Revenue Rankings